132:poster Cost-effectiveness of using hydroxyurea to treat sickle cell anemiain uganda: a model-based comparison of two dosing regimens

• Bjarne Robberstad,
• Bjørn Blomberg,
• Russell E Ware,
• Robert O Opoka,
• David Teigen,
• Philip Kasirye,
• Catherine Nabaggala,
• Heather A Hume,
• Chandy C John

Affiliations

Bjarne Robberstad

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway

Bjørn Blomberg

National Advisory Unit on Tropical Infectious Diseases, Haukeland Universitetssjukehus, Bergen, Norway

Russell E Ware

1 Division of Hematology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA

Robert O Opoka

Department of Paediatrics and Child Health, Mulago Hospital/Makerere University College of Health Sciences, Kampala, Uganda

David Teigen

1Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway

Philip Kasirye

2Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda

Catherine Nabaggala

2Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda

Heather A Hume

4Centre hospitalier universitaire Ste-Justine, Université de Montréal, Montréal QC, Canada

Chandy C John

7Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, IN, USA